GLP-1s

Marietta, Ga.-based MiMedx Group's EpiFix diabetic foot ulcer treatment will now be covered by Hartford, Conn.-based payer Aetna.

Louisville, Ky.-based Humana will conditionally cover Sarepta Therapeutics' recently approved Duchenne muscular dystrophy drug.

Tampa, Fla.-based Moffitt Cancer Center and payer UnitedHealthcare launched a value-based payment model for lung cancer treatment effective Oct. 1.

A recent study published in Health Affairs found states that legalized medical marijuana saw a slight decrease in Medicare prescription use and Medicare Part D spending, Kaiser Health News reported.

Autopsy results released Thursday show Prince Rogers Nelson, the music legend commonly known as Prince, died from fentanyl toxicity.

Independent Blue Cross and Culver City, Calif.-based NantHealth have agreed to provide insurance coverage for a comprehensive whole genome and proteome diagnostic platform to diagnose molecular differences in an individual's cancer and identify personalized therapies.

The U.S. Food and Drug Administration awarded 15 grants, totaling more than $19 million, for the development of medical device, drug and biological products for patients suffering with rare diseases.

Personalized medicine — using genomic information to inform medical treatment decisions — is no doubt the future of healthcare. Having a patient's detailed genetic information and using it to inform clinical decision making will reduce diagnostic error and improve treatment…

Dallas-based Pinnacle Anesthesia and Orlando-based JLR Medical Group announced that they will join Greater Houston Anesthesiology as founding partners in U.S. Anesthesia Partners, an anesthesia-focused physician services organization.

In 2013, more than 35 million Medicare beneficiaries were enrolled in Medicare drug plans, according to a Kaiser Family Foundation report.